Pichardo BR, Ávila VR, Muñoz HDE, Barredo PBA

Language: Spanish
References: 14
Page: 103-107
PDF size: 296.29 Kb.

ABSTRACT

Objective: To describe and compare the histopatological features of the breast carcinoma in a Third Level Hospital compared with the world literature data. Material and methods: It was done a search on Medica Sur Pathologic Anatomy Database in the period between the year 1999 and 2003. It was done a square chi probe and a proportion difference probe with Microsoft Excel. Results: It was done in this period 1,043 procedures. 37.48% of the population had fibroquistic condition, 18.88% a malignant epithelial neoplasm and 16.87% a mixed neoplasm. About the malignant epithelial neoplasm the 84% is infiltrant, 70.39% by ductal histologic type and 14.53% lobulillar. The rest are carcinoma in situ, ductal with 3.91%, lobular with 3.91% and the rest by other types of carcinoma. Conclusions: There is a difference between the histologic types of carcinoma in Medica Sur and the world literature data. The Mexican population had differences between the histologic type of breast cancer; thus, the elaboration of new studies about the epidemiology of breast cancer in Mexico is necessary.

REFERENCES

1. Mohar A, Frías MM, Suchil BB, Mora MT, de la Garza JG. Epidemiología descriptiva del cáncer en el Instituto Nacional de Cancerología de México. Salud Publica Mex 1997; 39: 253-258.

2. Pérez TR. El cáncer en México. Primera Edición México: El Colegio Nacional 2003: 407-442.

3. López-Ríos O, Lazcano PEC, Tovar GV, Hernández AM. La epidemia de cáncer de mama en México. ¿Consecuencia de la transición demográfica? Salud Publica Mex 1997; 39: 259-265.

4. Pérez TR. El cáncer en México. México: El Colegio Nacional 2003: 235-272.

5. Tavassoli FA. Pathology of the breast. Segunda Edición. Hong Kong: Mc Graw Hill 1999: 27-59.

6. Kumar V, Abbas A, Fausto N. Robbins and Cotran pathologic basis of the disease. Cuarta Edición Filadelfia: Elsevier Saunders 2004: 1129-1151.

7. Seltzer MH. Breast complaints, biopsies, and cancer correlated with age in 10,000 consecutive new surgical referrals. Breast J 2004; 10: 111- 117.

8. Lay SF, Crump JM, Frykberg ER, Goedde TA, Copeland EM. Breast biopsy. Changing paterns on a five year period. Am Surg 1990; 56: 79-85.

9. Dixon JM, Page DL, Anderson TJ, Lee D, Elton RA, Stewart HJ, Forrest AP. Long term survivors after breast cancer. Br J Surg 1985; 72(6): 445-448.

10. Van Rijk MC, Deurloo EE, Nieweg OE, Gilhuijs KGA, Petherse JL, Rutgers EJT, Kröger R, Kroon BBR. Ultrasonography and fine needle aspiration citology can spare breast cancer patients unnecessary sentinel node biopsy. Ann Surg Oncol 2003; 13: 31-35.

11. Mehrdad N, Gómez-Fernández C, Ganjei-Azar P, Morales A. Immunohistochemestry of estrogen and progesterone receptors reconsidered: Experience with 5,993 cancers. Am J Clin Pathol 2005; 123: 21-7.

12. Turashvili G, Bouchal J, Burkadze G, Kolá Z. Differentiation of tumors of ductal and lobulillar origin: I. Proteomics of invasive ductal and lobulillar breast carcinomas: I. Proteomics of invasive ductal and lobular breast carcinoma. Biomed Papers 2005; 146: 57-62.

13. Turashvili G, Bouchal J, Burkadze G, Kolá Z. Differentiation of tumors of ductal and lobulillar origin: II. Genomics of invasive ductal and lobulillar breast carcinomas: I. Proteomics of invasive ductal and lobular breast carcinoma. Biomed Papers 2005; 149: 63-8.

14. Turashvili G, Bouchal J, Erhman J, Fridman E, Skarda J, Kolá Z. Novel inmunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007; 151: 59-64.